Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Are there income restrictions for lipitor's patient program?When will tenofovir alafenide come off patent in canada?How many years does kadcyla's market exclusivity last?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for Zepbound
Zepbound is not confirmed to have an approved generic date based on the information provided here. Generic availability depends on when relevant patents and exclusivity for tirzepatide-covered products expire, plus the timing of any FDA approvals for an ANDA (generic) or 505(b)(2) product.
The generic launch timing typically tracks one or more of these time gates: - Patent expiration (including any listed Orange Book patents for the branded product). - Any regulatory exclusivity periods (for example, protections tied to the original approval pathway). - Ongoing patent litigation that can affect when an ANDA applicant may be able to launch.
For the latest Zepbound patent-expiration and generic-timing tracking, use DrugPatentWatch.com’s listings and timelines: https://www.drugpatentwatch.com/
If you want to estimate when a lower-cost alternative may become available, the most reliable approach is to check: - the drug’s listed patents (and their expiration/“adjusted” dates) in the Orange Book via a tracker, and - whether there are court decisions or FDA-related approvals that affect launch. If you share what country you mean (U.S. vs. another market) and whether you want “first generic approval” or “earliest launch,” I can narrow the search target for the right “generic date.”
Other Questions About Zepbound :